Skip to content

Brief Shame Intervention Study

The Development and Evaluation of a Brief Shame Intervention Module: Proof of Concept in Social Anxiety Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03463356
Enrollment
14
Registered
2018-03-13
Start date
2018-02-15
Completion date
2018-06-30
Last updated
2019-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shame, Social Anxiety Disorder

Brief summary

The current project will develop and test a brief 2-session shame intervention in individuals diagnosed with social anxiety disorder (SAD). Using a non-concurrent multiple baseline design, the investigators will determine whether the brief shame intervention leads to reductions in trait self-reported shame and state shame in response to an in vivo stressor task. The investigators will also evaluate the effect of changes in shame on trait SAD symptoms.

Interventions

BEHAVIORALShame Intervention

In the Shame Intervention, participants will meet with a therapist and learn to: 1) Recognize the experience of shame, 2) Understand the connection between shame and social anxiety, 3) Identify shame triggers and vulnerabilities, 4) Identify the thoughts and behaviors that keep participants stuck in shame, and 5) Learn how to use new, healthier thoughts and behaviors that will help participants move through and decrease shame.

Sponsors

Miami University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

non-concurrent multiple baseline design

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

-≥ 18 years old * fluent in English, in terms of verbal and written competence * meet diagnostic criteria for social anxiety disorder (as assessed by the Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders; Tolin et al., 2016) * have elevated levels of shame (i.e., score 1 SD above the Test of Self-Conscious Affect-3 \[TOSCA-3\] means reported by an unselected undergraduate sample \[M = 33.62, SD = 8.64\]) * endorse a desire to decrease their levels of shame and/or social anxiety.

Exclusion criteria

* currently receiving cognitive-behavioral therapy specifically for social anxiety or shame * have begun taking or had a change in dosage of psychotropic medication in the past six weeks * do not achieve baseline stability

Design outcomes

Primary

MeasureTime frameDescription
Change in Test of Self-Conscious Affect-3-Short FormParticipants indicate likelihood of responses to scenarios. Administered at B1-B5 and T1-T5. B1-B5 occur ~1 week apart. T1 occurs ~1 week after the final baseline. T1-T4 each occur within ~2 weeks of each other. T5 occuring ~1 month after T4.Self-report of how likely an individual is to react to 11 scenarios with shame responses

Secondary

MeasureTime frameDescription
Change in Liebowitz Social Anxiety-Self-ReportParticipants report on symptoms during the past week. Administered at T1-T5. T1-T4 each occur within ~2 weeks of each other. T5 occurs ~1 month after T4.Self-report of social anxiety symptoms
Change in Brief State Anxiety MeasureParticipants report on symptoms experienced during the speech task. Administered at T1 and T4. T4 occurs within ~6 weeks after T1.Self-report of levels of anxiety experienced during the speech task
Change in Shame InventoryParticipants report on typical experience of symptoms. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.Self-report of shame symptoms
Change in State Shame and Guilt MeasureParticipants report on symptoms experienced during the speech task. Administered at T1 and T4. T4 occurs within ~6 weeks after T1.Self-report of levels of shame experienced during the speech task

Other

MeasureTime frameDescription
Change in Self Beliefs about Social AnxietyParticipants report on typical experience of symptoms. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.Self-report measure of social anxiety disorder relevant maladaptive beliefs
Change in Center for Epidemiologic Studies Depression MeasureParticipants report on symptoms experienced during the past week. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.Self-report measure of depressive symptoms
Change in Clinical Perfectionism MeasureParticipants report on symptoms experienced during the past month. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.Self-report measure of perfectionism
Change in Eating Disorder Inventory - 3rd VersionParticipants report on typical experience of symptoms. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.Self-report measure of eating disorder symptoms
Change in Brief Fear of Negative Evaluation Measure-IIParticipants report on typical experience of symptoms. Administered at T1, T4, and T5. T4 occurs within ~6 weeks after T1. T5 occurs ~1 month after T4.Self-report measure of fear of negative evaluation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026